Correct me if I'm wrong, but isn't this CBD line of products like all other supplement lines? It seems as though even the CBD space itself is a bit crowded already.
I would tend to think that their MSE line of supplements will still have to be their primary source of revenues going forward. Maybe I'm wrong.
I'll be perfectly honest, too, in that the only reason I'm at all still interested in this company is because of their CBD product line coming out, because I believe it will attract traders that would otherwise have no interest here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.